Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IMNM
#1681
Immunome, Inc.
21.8
6
+1.30%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+1.30%
Monthly Change
-14.81%
6 month change
+119.26%
Year Change
+151.55%
Previous Close
21.5
8
Open
21.8
6
Bid
Ask
Low
21.8
6
High
21.8
6
Volume
116
Markets
US Stock Market
Healthcare
IMNM
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
10.66 M
12.13 M
12.22 M
59.69 M
86.95 M
—
Valuation ratios
Enterprise value
63.42 M
107.94 M
19.5 M
558.55 M
780.02 M
2.57 B
Price to earnings ratio
—
-6.06
-1.06
-2.05
-2.12
-11.77
Price to sales ratio
—
14.95 K
7 906.53
13.05
28.46
114.42
Price to cash flow ratio
—
8.2
1.38
28.87
5.62
17.03
Price to book ratio
—
3.1
2.37
1.82
3.44
5.47
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.4
0.43
1.53
0.72
1.22
0.79
Return on equity %
0.43
0.51
2.22
0.89
1.62
0.96
Return on invested capital %
2 229.27
2 415.33
3 126.87
4 185.73
3 469.78
—
Gross margin %
100
100
100
100
100
400
Operating margin %
32.27 K
252.04 K
738.02 K
654.22
1 397.75
5 171.71
EBITDA margin %
—
—
—
—
—
—
Net margin %
46.84 K
247 K
738 K
637.92
1 339.08
4 927.86
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
14.12
5.82
3.09
6.63
4.08
35.6
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0.19
0.11
0.07
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
0
—
—
—
—
Long term debt to total equity ratio
0
0
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.58
2.37
0.38
1.89
2.41
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
4.27
1.68
6.96
3.71
13.88
Net current asset value per share
—
4.91
1.87
7.29
3.77
14.21
Tangible book value per share
—
4.18
1.37
6.04
3.09
13.05
Working capital per share
—
4.07
1.26
6.19
2.85
12.28
Book value per share
—
4.18
1.37
6.04
3.09
13.05
News
Immunome stock hits 52-week high at $26.74
Immunome stock reaches 52-week high at $25.32
Immunome (IMNM) CEO Siegall buys $100k in shares
Guggenheim reiterates Buy rating on Immunome stock following $400M financing
Tsai Philip buys $204,899 in Immunome stock
Immunome: Maintaining "Strong Buy" On Successful RINGSIDE Trial With Varegacestat (IMNM)
Avago and Oracle among market cap stock movers on Wednesday
Oracle and Shopify among market cap stock movers on Wednesday
Immunome stock falls after pricing $400 million share offering
Immunome prices public offering of common stock at $21.50 per share
Immunome stock price target raised to $35 by Guggenheim on positive trial data
Evercore ISI raises Immunome stock price target to $40 on positive trial data